Clinical & translational oncology

• 

  Año 2013, Vol. 15, Número 11

  • Has discovery-based cancer research been a bust?

    R. J. Epstein

    • Resumen

    págs. 865-870

    

  • Zoledronic acid in genitourinary cancer

    Miguel Ángel Climent Durán, Urbano Anido Herranz, María José Méndez Vidal, Javier Puente Vázquez

    • Resumen

    págs. 871-878

    

  • New sequencing technologies

    Ivo Glynne Gut

    • Resumen

    págs. 879-881

    

  • Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis

    J. Li, Z.-N. Li, L.-C. Yu, S.-B. Shi, L.-P. Ge, J.-R. Wu, Y.-M. Hu

    • Resumen

    págs. 882-888

    

  • Early volumetric change and treatment outcome of metastatic brain tumors after external beam radiotherapy: differential radiotherapy for brain metastasis

    D. S. Lee, Y. S. Kim, C. G. Lee, J. H. Lim, C.-O. Suh, J.-H. Kim, Jaeho Cho

    • Resumen

    págs. 889-896

    

  • VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer

    Tania Fleitas, Vicenta Martínez-Sales, Virtudes Vila Liante, Edelmiro Reganon Salvador, D. Mesado, M. Martín, José Gómez Codina, Joaquín Montalar Salcedo, Gaspar Reynés Muntaner

    • Resumen

    págs. 897-902

    

  • Predictive and prognostic value of LPS-stimulated cytokine secretion in metastatic non-small cell lung cancer

    P. J. Vlachostergios, I. Gioulbasanis, S. Ghosh, C. Tsatsanis, G. Papatsibas, A. Xyrafas, E. Hatzidaki, C. Vasiliou, K. Kamposioras, S. Agelaki, A. N. Margioris, D. Nasi, V. Georgoulias, C. N. Papandreou

    • Resumen

    págs. 903-909

    

  • Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer

    Anni Innamaa, L. Jackson, Viren Asher, G. van Schalkwyk, A. Warren, A. Keightley, D. Hay, Anish Bali, H. Sowter, R. Khan

    • Resumen

    págs. 910-918

    

  • Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma

    P. Pedicini, A. Fiorentino, G. Improta, A. Nappi, M. Salvatore, G. Storto

    • Resumen

    págs. 919-924

    

  • Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience

    Jon Cacicedo Fernández de Bobadilla, Francisco Casquero Ocio, Olga del Hoyo Álvarez, A. Gómez-Iturriaga, Lorea Martínez Indart, José Luis López Guerra, Pedro Bilbao Zulaica

    • Resumen

    págs. 925-931

    

  • The application of ultrasonic harmonic scalpel in the radical surgery of gastric cancer

    Y. Huang, G. C. Mu, X. G. Qin, J. L. Lin, C. Liu, Z. B. Chen, Y. J. Zeng

    • Resumen

    págs. 932-937

    

  • Prognostic significance of annexin II expression in non-small cell lung cancer

    C.-H. Luo, Q.-Q. Liu, P.-F. Zhang, M.-Y. Li, Z.-C. Chen, Y.-F. Liu

    • Resumen

    págs. 938-946

    

  • Up-regulation of nuclear receptor coactivator amplified in breast cancer-1 in papillary thyroid carcinoma correlates with lymph node metastasis

    M.-Y. Liu, H.-P. Guo, C.-Q. Hong, H.-W. Peng, X.-H. Yang, H. Zhang

    • Resumen

    págs. 947-952

    

  • Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study

    J. Osman, S. Galli, M. Hanafy, X. Tang, A. Ahmed

    • Resumen

    págs. 953-958

    

  • Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?

    Diego Márquez Medina, A. Chachoua, A. Martín Marco, A. M. Desai, V. García Reglero, Antonieta Salud, F. Muggia

    • Resumen

    págs. 959-964

    

  • Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens

    E. E. Habib, E. S. Fahmy

    • Resumen

    págs. 965-968

    

  • Assessment of p38? in peripheral blood mononuclear cells (PBMC): a potential blood protein marker of head and neck squamous cell carcinoma

    K. Gill, R. Kumar, B. Kalyan Mohanti, S. Dey

    • Resumen

    págs. 969-973